SDJVC
LGND icon

St. Denis J. Villere & Co’s Ligand Pharmaceuticals LGND Stock Holding History

St. Denis J. Villere & Co’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2M Sell
155,506
-33,368
-18% -$7.86M 5.87% 1
2026
Q1 		$37.7M Sell
188,874
-13,578
-7% -$2.69M 4.16% 2
2025
Q4 		$38.3M Sell
202,452
-77,498
-28% -$14.9M 3.84% 4
2025
Q3 		$49.6M Sell
279,950
-7,170
-2% -$1.07M 4.77% 2
2025
Q2 		$32.6M Sell
287,120
-1,707
-0.6% -$182K 3.14% 10
2025
Q1 		$30.4M Buy
288,827
+1,783
+0.6% +$202K 2.93% 13
2024
Q4 		$30.8M Sell
287,044
-187,814
-40% -$21.2M 2.78% 14
2024
Q3 		$47.5M Sell
474,858
-9,055
-2% -$912K 3.88% 3
2024
Q2 		$40.8M Sell
483,913
-6,839
-1% -$544K 3.45% 5
2024
Q1 		$35.9M Buy
490,752
+62,701
+15% +$4.62M 2.86% 13
2023
Q4 		$30.6M Sell
428,051
-10,110
-2% -$597K 2.52% 19
2023
Q3 		$26.3M Sell
438,161
-41,286
-9% -$2.72M 2.24% 23
2023
Q2 		$34.6M Sell
479,447
-1,360
-0.3% -$102K 2.5% 19
2023
Q1 		$35.4M Sell
480,807
-2,540
-0.5% -$181K 2.57% 17
2022
Q4 		$32.3M Sell
483,347
-303,898
-39% -$19.8M 2.52% 16
2022
Q3 		$42.3M Sell
787,245
-7,888
-1% -$464K 3.37% 9
2022
Q2 		$44.3M Sell
795,133
-23,748
-3% -$1.35M 3.31% 13
2022
Q1 		$57.5M Sell
818,881
-13,057
-2% -$947K 3.41% 14
2021
Q4 		$80.2M Sell
831,938
-72,713
-8% -$6.72M 4.6% 6
2021
Q3 		$78.6M Sell
904,651
-48,140
-5% -$3.72M 4.58% 2
2021
Q2 		$78M Buy
952,791
+91,935
+11% +$7.65M 4.18% 11
2021
Q1 		$81.9M Sell
860,856
-168,387
-16% -$15.9M 4.48% 9
2020
Q4 		$63.9M Sell
1,029,243
-34,160
-3% -$1.95M 3.85% 13
2020
Q3 		$63.2M Buy
1,063,403
+25,191
+2% +$1.72M 4.25% 11
2020
Q2 		$72.4M Buy
1,038,212
+19,092
+2% +$1.21M 5.19% 7
2020
Q1 		$46.2M Buy
+1,019,120
New +$57.8M 3.94% 9

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

St. Denis J. Villere & Co's LGND Position: Q2 2026 in Review

St. Denis J. Villere & Co reduced its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, selling an estimated $7.86M and leaving 155,506 shares worth $49.2M. The position accounts for 5.87% of the portfolio, ranked #1.

St. Denis J. Villere & Co first reported a position in LGND in Q1 2020 and has held it in 26 quarters since. The position peaked at $81.9M in Q1 2021. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • St. Denis J. Villere & Co held 155,506 shares of Ligand Pharmaceuticals worth $49.2M as of Q2 2026.
  • St. Denis J. Villere & Co sold 33,368 Ligand Pharmaceuticals shares in Q2 2026, an estimated $7.86M.
  • Ligand Pharmaceuticals made up 5.87% of St. Denis J. Villere & Co's portfolio in Q2 2026, its #1 holding.
  • St. Denis J. Villere & Co first reported a position in Ligand Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • St. Denis J. Villere & Co's Ligand Pharmaceuticals position peaked at $81.9M in Q1 2021.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on St. Denis J. Villere & Co's 13F filing for Q2 2026, filed 7 Aug 2026.